What is the meaning of LIFE? Implications of the Losartan Intervention for Endpoint reduction in hypertension trial for heart failure physicians.
Massie
Barry M
BM
Cardiology Section, Veterans Affairs Medical Center, San Francisco, California 94121, USA.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D023381:Endpoint Determination; D006333:Heart Failure / Q000150:complications* / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy* / Q000453:epidemiology; D017379:Hypertrophy, Left Ventricular / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology; D019808:Losartan / Q000627:therapeutic use*; D010820:Physicians; D011945:Receptors, Angiotensin / Q000627:therapeutic use; D012307:Risk Factors; D016896:Treatment Outcome; D006113:United Kingdom / Q000453:epidemiology; D014481:United States / Q000453:epidemiology
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D011945:Receptors, Angiotensin; D019808:Losartan